Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.8481
-0.0259 (-2.96%)
At close: Oct 15, 2025, 4:00 PM EDT
0.8481
0.00 (0.00%)
Pre-market: Oct 16, 2025, 5:14 AM EDT

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $174.00K in the quarter ending May 31, 2025, with 107.14% growth. This brings the company's revenue in the last twelve months to $615.92K, up 49.85% year-over-year. In the fiscal year ending August 31, 2024, Lexaria Bioscience had annual revenue of $464.28K with 105.24% growth.

Revenue (ttm)
$615.92K
Revenue Growth
+49.85%
P/S Ratio
23.45
Revenue / Employee
$87,989
Employees
7
Market Cap
18.86M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 2024464.28K238.07K105.24%
Aug 31, 2023226.21K-29.19K-11.43%
Aug 31, 2022255.40K-467.34K-64.66%
Aug 31, 2021722.74K407.95K129.59%
Aug 31, 2020314.79K92.18K41.41%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings